GCVTX
Price
$23.78
Change
+$0.17 (+0.72%)
Updated
Jun 26 closing price
Net Assets
521.44M
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

GCVTX vs RMEBX

Header iconGCVTX vs RMEBX Comparison
Open Charts GCVTX vs RMEBXBanner chart's image
Goldman Sachs Large Cp Val Insghts I
Price$23.78
Change+$0.17 (+0.72%)
VolumeN/A
Net Assets521.44M
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
GCVTX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCVTX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVTX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. GCVTX (521M). RMEBX pays higher dividends than GCVTX: RMEBX (1.16) vs GCVTX (1.09). GCVTX was incepted earlier than RMEBX: GCVTX (18 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than GCVTX (0.77). GCVTX is a more actively managed with annual turnover of: 206.00 vs. RMEBX (31.00). GCVTX has a lower initial minimum investment than RMEBX: GCVTX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. GCVTX (-1.32). RMEBX return over 5 years is better than : 62.71 vs. GCVTX (37.95).
GCVTXRMEBXGCVTX / RMEBX
Total Expense Ratio0.671.0763%
Annual Report Gross Expense Ratio0.771.0772%
Fund Existence18 years11 years-
Gain YTD2.7297.31537%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets521M106B0%
Annual Yield % from dividends1.091.1694%
Returns for 1 year-1.329.50-14%
Returns for 3 years17.8725.8869%
Returns for 5 years37.9562.7161%
Returns for 10 years58.1774.5178%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp